Short Interest in Advanced Biomed Inc. (NASDAQ:ADVB) Declines By 72.7%

Advanced Biomed Inc. (NASDAQ:ADVB) was the target of a large decrease in short interest during the month of April. As of April 30th, there was short interest totaling 13,424 shares, a decrease of 72.7% from the April 15th total of 49,188 shares. Based on an average daily trading volume, of 44,188 shares, the days-to-cover ratio is currently 0.3 days. Approximately 1.5% of the shares of the stock are short sold.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings started coverage on Advanced Biomed in a report on Monday, January 26th. They issued a “sell (e+)” rating for the company. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has a consensus rating of “Sell”.

Advanced Biomed Stock Down 9.2%

NASDAQ ADVB opened at $4.75 on Thursday. The business’s 50 day simple moving average is $5.19. Advanced Biomed has a one year low of $3.61 and a one year high of $25.80. The firm has a market capitalization of $6.46 million, a PE ratio of 1.25 and a beta of 0.56.

About Advanced Biomed

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.